Reports on a randomized controlled trial of HIV-infected men and women who, as a result of receiving selenium supplements, experienced lower HIV viral load and greater CD4 cell count.
Offers an overview of some of the NIDA-supported innovative research achievements to reduce the health and social effects of drug abuse and addiction.
Describes research to develop new compounds that match or exceed the pain relief provided by opioids while avoiding their shortcomings.
Describes a study of unemployed methadone patients and the use of assertive outreach and motivational techniques to improve the patients’ employment outlook.
Presents highlights of a meeting of scientists and clinicians to review research results from the field of social neuroscience, the study of how neurobiology and the social environment interact.
Highlights the work of investigators who discovered key ways in which morphine may accelerate the progression of AIDS in animal studies.
Highlights the NIDA International Program which works to strengthen international research networks, creating opportunities for global research collaboration, training, and scientific exchange.
Describes a new intervention that enhances recovery prospects for substance abusers whose mental illness complicates the path toward recovery.
Describes a study investigating the use of the antidepressant bupropion as a potential therapy for methamphetamine addiction.
Describes a new research finding indicating that the antidepressant sertraline (Zoloft), prescribed to relieve depression during the methamphetamine withdrawal process, may make quitting harder.